NCT02797821View on ClinicalTrials.gov

Pharmacokinetic and Dose Response Study of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia (HPP)

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

June 6, 2016

Primary Completion Date

June 21, 2017

Study Completion Date

June 21, 2017

Conditions
Hypophosphatasia
Interventions
DRUG

Asfotase alfa

Trial Locations (4)

27710

Duke University Medical Center, Durham

37232

Vanderbilt Medical Center Endocrinology, Nashville

63110

Shriners Hospitals for Children, St Louis

97074

University of Würzburg, Würzburg

Sponsors
All Listed Sponsors
lead

Alexion Pharmaceuticals, Inc.

INDUSTRY